StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics cash

Cash and short-term investments held at the end of each period.

TransMedics's cash was $472.68M at Jun 30, 2026. For fiscal 2025 it was $488.37M, up 44.9% from the year before. The highest annual figure on record is $488.37M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$488.37M+44.9%
FY2024Dec 31, 2024$337.15M-14.6%
FY2023Dec 31, 2023$394.81M+95.8%
FY2022Dec 31, 2022$201.68M+118.0%
FY2021Dec 31, 2021$92.50M-26.4%
FY2020Dec 31, 2020$125.60M+55.6%
FY2019Dec 28, 2019$80.70M+289.1%
FY2018Dec 29, 2018$20.74M+66.8%
FY2017Dec 30, 2017$12.44M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$472.68M+18.0%
Q1 FY2026Mar 31, 2026$461.74M+48.9%
Q4 FY2025Dec 31, 2025$488.37M+44.9%
Q3 FY2025Sep 30, 2025$466.17M+41.2%
Q2 FY2025Jun 30, 2025$400.58M+10.4%
Q1 FY2025Mar 31, 2025$310.14M-11.4%
Q4 FY2024Dec 31, 2024$337.15M-14.6%
Q3 FY2024Sep 30, 2024$330.09M-22.7%
Q2 FY2024Jun 30, 2024$362.75M-37.7%
Q1 FY2024Mar 31, 2024$350.22M+79.3%
Q4 FY2023Dec 31, 2023$394.81M+95.8%
Q3 FY2023Sep 30, 2023$427.11M+108.9%
Q2 FY2023Jun 30, 2023$582.21M+902.1%
Q1 FY2023Mar 31, 2023$195.38M+171.4%
Q4 FY2022Dec 31, 2022$201.68M+118.0%
Q3 FY2022Sep 30, 2022$204.50M+98.7%
Q2 FY2022Jun 30, 2022$58.10M-48.2%
Q1 FY2022Mar 31, 2022$72.00M-39.0%
Q4 FY2021Dec 31, 2021$92.50M-26.4%
Q3 FY2021Sep 30, 2021$102.90M-22.5%
Q2 FY2021Jun 30, 2021$112.20M-19.5%
Q1 FY2021Mar 31, 2021$118.10M+62.7%
Q4 FY2020Dec 31, 2020$125.60M+55.6%
Q3 FY2020Sep 30, 2020$132.70M+50.3%
Q2 FY2020Jun 30, 2020$139.40M+44.9%
Q1 FY2020Mar 31, 2020$72.60M+494.4%
Q4 FY2019Dec 28, 2019$80.70M+289.1%
Q3 FY2019Sep 28, 2019$88.30M+200.4%
Q2 FY2019Jun 29, 2019$96.20M+175.3%
Q1 FY2019Mar 30, 2019$12.22M+18.6%
Q4 FY2018Dec 29, 2018$20.74M+66.8%
Q3 FY2018Sep 29, 2018$29.39M–
Q2 FY2018Jun 30, 2018$34.94M–
Q1 FY2018Mar 31, 2018$10.30M–
Q4 FY2017Dec 30, 2017$12.44M–

More TransMedics figures

See a number that looks wrong?